Prevent Cancer Foundation welcomes 2025 corporate members advancing cancer prevention and early detection
FOR IMMEDIATE RELEASE
Audrey Kashatus
703-836-3687
audrey.kashatus@preventcancer.org
Alexandria, Va. – The Prevent Cancer Foundation® proudly welcomes its largest-ever cohort—16 leading companies—as 2025 members of the Corporate Membership Program. These organizations join a growing community dedicated to advancing cancer prevention and early detection nationwide.
“In just two years, our Corporate Membership Program has grown into a thriving community of partners dedicated to cancer prevention and early detection,” said Jody Hoyos, CEO of the Prevent Cancer Foundation. “These corporate partners share our commitment to saving lives, and by collaborating with industry leaders, we’re reaching more people and helping them take charge of their health.”
The 2025 class of corporate members, as of the date of this publication, include:
Silver members
- Exact Sciences
- Hologic
- Ipsen
- Pfizer
- PhRMA
Bronze members
- AstraZeneca
- AVEO Oncology
- Amgen
- BMS
- Eisai
- Genentech
- Geneoscopy
- Guardant
- Lilly
- Merck
- Natera
- Sanofi
Through the Corporate Membership Program, business leaders help expand the Foundation’s reach and impact. Members participate in Foundation events, including industry roundtables, to collaborate and exchange ideas throughout the year. Membership supports the Foundation’s work in four key areas: research, education, outreach and advocacy.
The Corporate Membership Program is open to companies who share the Foundation’s vision of a world where cancer is preventable, detectable and beatable for all. To learn more or inquire about joining, contact Jennifer Niyangoda, Vice President of Development and Marketing, at jennifer.niyangoda@preventcancer.org.
###
About the Prevent Cancer Foundation®
The Prevent Cancer Foundation® is the only U.S.-based nonprofit organization solely dedicated to cancer prevention and early detection. Through research, education, outreach and advocacy, we have helped countless people avoid a cancer diagnosis or detect their cancer early enough to be successfully treated. We are driven by a vision of a world where cancer is preventable, detectable and beatable for all.
The Foundation is rising to meet the challenge of reducing cancer deaths by 40% by 2035. To achieve this, we are committed to investing $20 million for innovative technologies to detect cancer early and advance multi-cancer screening, $10 million to expand cancer screening and vaccination access to medically underserved communities, and $10 million to educate the public about screening and vaccination options.
For more information, please visit www.preventcancer.org.